Revisiting Molecular Mechanisms in Diabetic Nephropathy: An Updated Review

Molecular Insights of Diabetic Nephropathy

Authors

  • Ganesh Pawar Department of Pharmacology, Kamalprakash pharmacy College and Research Centre Kherda, Karanja (Lad) Dist. Washim, Maharashtra India- 444107
  • Jagadish V. Manwar Department of Pharmacology, Kamalprakash pharmacy College and Research Centre Kherda, Karanja (Lad) Dist. Washim, Maharashtra India- 444107
  • Bhushan G. Gudalwar Department of Pharmacology, Kamalprakash pharmacy College and Research Centre Kherda, Karanja (Lad) Dist. Washim, Maharashtra India- 444107
  • Anjali Aldurge Department of Pharmacology, Kamalprakash pharmacy College and Research Centre Kherda, Karanja (Lad) Dist. Washim, Maharashtra India- 444107

DOI:

https://doi.org/10.61920/jddb.v1i05.116

Keywords:

Diabetic nephropathy, glomerular hypertrophy, hyperfiltration, renal fibrosis, oxidative stress

Abstract

Diabetic nephropathy (DN) stands as a critical complication of diabetes mellitus, often culminating in end-stage renal disease (ESRD). The intricate molecular mechanisms underlying DN progression necessitate comprehensive exploration for effective therapeutic interventions. This review outlines key molecular insights into DN pathogenesis, including glomerular hypertrophy and hyperfiltration driven by hyperglycaemia-induced renal vasodilation. Renal fibrosis, characterized by ECM protein accumulation, is mediated by TGF-β signalling. Chronic low-grade inflammation, oxidative stress, and activation of the renin-angiotensin-aldosterone system (RAAS) contribute significantly to renal injury. Epigenetic modifications, such as DNA methylation and non-coding RNA regulation, further influence gene expression patterns in response to hyperglycaemia. Dysregulated signalling pathways including PKC, NF-κB, and mTOR play pivotal roles in cellular responses to hyperglycaemia and oxidative stress. Understanding these molecular mechanisms offers potential therapeutic targets, including agents targeting inflammation, oxidative stress, and fibrosis, alongside strategies for glycaemic and blood pressure control. Emerging therapies targeting epigenetic regulators and cellular signalling pathways hold promise for preventing and treating diabetic nephropathy.

 

Author Biography

Anjali Aldurge, Department of Pharmacology, Kamalprakash pharmacy College and Research Centre Kherda, Karanja (Lad) Dist. Washim, Maharashtra India- 444107

Kamalprakash Pharmacy college and Research Centre, Kherda, Karanja (Lad) Dist. Washim, Maharashtra, India-444107

Downloads

Published

2024-04-28

How to Cite

Pawar, G., Manwar, J., Gudalwar, B., & Aldurge, A. (2024). Revisiting Molecular Mechanisms in Diabetic Nephropathy: An Updated Review: Molecular Insights of Diabetic Nephropathy. Journal of Drug Delivery and Biotherapeutics, 2(04), 33–41. https://doi.org/10.61920/jddb.v1i05.116